Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

313 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
EANM expert opinion: How can lessons from radiobiology be applied to the design of clinical trials? Part I: back to the basics of absorbed dose-response and threshold absorbed doses.
Pouget JP, Gabina PM, Herrmann K, Deandreis D, Konijnenberg M, Taieb D, van Leeuwen FWB, Kurth J, Eberlein U, Lassmann M, Lückerath K; EANM Radiobiology Working Group. Pouget JP, et al. Among authors: taieb d. Eur J Nucl Med Mol Imaging. 2024 Nov 12. doi: 10.1007/s00259-024-06963-9. Online ahead of print. Eur J Nucl Med Mol Imaging. 2024. PMID: 39531084 Review.
[Guidelines of the French National ENDOCAN-COMETE, Association of Endocrine Surgery, Society of Urology for the management of adrenocortical carcinoma].
Libé R, Haissaguerre M, Renaudin K, Faron M, Decaussin-Petrucci M, Deschamps F, Gimenez-Roqueplo AP, Mirallie E, Murez T, Pattou F, Rocher L, Taïeb D, Savoie PH, Tabarin A, Bertherat J, Baudin E, de la Fouchardière C. Libé R, et al. Among authors: taieb d. Bull Cancer. 2023 Jun;110(6):707-730. doi: 10.1016/j.bulcan.2023.03.015. Epub 2023 Apr 13. Bull Cancer. 2023. PMID: 37061367 Free article. French.
MERAIODE: A Phase II Redifferentiation Trial with Trametinib and 131I in Metastatic Radioactive Iodine Refractory RAS Mutated Differentiated Thyroid Cancer.
Leboulleux S, Benisvy D, Taieb D, Attard M, Bournaud C, Terroir-Cassou-Mounat M, Lacroix L, Anizan N, Schiazza A, Garcia ME, Ghuzlan AA, Lamartina L, Schlumberger M, Godbert Y, Borget I. Leboulleux S, et al. Among authors: taieb d. Thyroid. 2023 Sep;33(9):1124-1129. doi: 10.1089/thy.2023.0240. Epub 2023 Jul 26. Thyroid. 2023. PMID: 37350119 Clinical Trial. No abstract available.
[French recommendations for malignant pheochromocytomas and paragangliomas by the national ENDOCAN-COMETE network].
de la Fouchardière C, Haissaguerre M, Decaussin-Petrucci M, Renaudin K, Deschamps F, Mirallié E, Murez T, Pattou F, Rocher L, Savoie PH, Faron M, Taieb D, Tabarin A, Bertherat J, Gimenez-Roqueplo AP, Amar L, Baudin E, Libé R. de la Fouchardière C, et al. Among authors: taieb d. Bull Cancer. 2023 Oct;110(10):1063-1083. doi: 10.1016/j.bulcan.2023.06.002. Epub 2023 Aug 10. Bull Cancer. 2023. PMID: 37573200 Free article. French.
Chapter 10: WHAT PARATHYROID IMAGING IS REQUIRED FOR HYPERPARATHYROIDISM?
Chevalier B, Ghander C, Ladsous M, Gaujoux S, Taieb D, Buffet C, Drui D, Lifante JC, Maione L, Lussey-Lepoutre C, Borson-Chazot F. Chevalier B, et al. Among authors: taieb d. Ann Endocrinol (Paris). 2025 Jan 14:101699. doi: 10.1016/j.ando.2025.101699. Online ahead of print. Ann Endocrinol (Paris). 2025. PMID: 39818294
313 results